|1.||Young, John A T: 3 articles (01/2011 - 06/2004)|
|2.||Melder, Deborah C: 2 articles (02/2015 - 12/2004)|
|3.||Federspiel, Mark J: 2 articles (02/2015 - 12/2004)|
|4.||Svoboda, Jan: 2 articles (02/2012 - 12/2004)|
|5.||White, Judith M: 2 articles (03/2003 - 03/2002)|
|6.||Delos, Sue E: 2 articles (03/2003 - 03/2002)|
|7.||VanBrocklin, Matthew W: 1 article (02/2015)|
|8.||Pike, Gennett M: 1 article (02/2015)|
|9.||Zhang, Huanmin: 1 article (01/2015)|
|10.||Kuo, Tzu-Hsing: 1 article (01/2015)|
02/01/2015 - "The study of the interactions of subgroup A avian sarcoma and leucosis viruses [ASLV(A)] with the TVA receptor required to infect cells offers a powerful experimental model of retroviral entry. "
01/01/2011 - "Avian sarcoma and leukosis virus Envelope protein (ASLV Env) mediates entry via a receptor, Tva, which can be attached to the cell surface either by a phospholipid anchor (Tva800) or a transmembrane domain (Tva950). "
02/01/2015 - "Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses."
01/01/2015 - "Intronic deletions of tva receptor gene decrease the susceptibility to infection by avian sarcoma and leukosis virus subgroup A."
01/01/2015 - "However, if the retrovirus is pseudotyped with an avian sarcoma leukosis virus (ASLV)-A envelope protein, only axolotl cells experimentally manipulated to express the cognate tumor virus A (TVA) receptor can be targeted by infections. "
02/01/2015 - "Two homologs of the TVA receptor have been cloned: the original quail TVA receptor, which has been the basis for most of the initial characterization of the ASLV(A) TVA, and the chicken TVA receptor, which is 65% identical to the quail receptor overall but identical in the region thought to be critical for infection. "
12/21/2007 - "To understand how this occurs, we investigated the role of the receptor Tva in avian leukosis virus-A (ALV-A) infection. "
06/01/2005 - "RCAS retroviral infections were targeted to melanoblasts (NC-M precursor cells) derived from transgenic mice that express the virus receptor, TVA, under the control of a melanoblast promoter (DCT). "
10/31/2003 - "Here we use this enhancer to restrict expression of the avian leukosis virus receptor, TVA, to hematopoietic stem cells and progenitors in bone marrow and fetal liver and demonstrate that retroviral infection can be used to specifically introduce exogenous sequences. "
03/15/2002 - "We examined each mutant EnvA for its ability to be expressed at the cell surface, proteolytically processed into gp85 and gp37, incorporated into MLV pseudotyped virions, and to support infection of cells expressing the ASLV-A receptor, Tva. "
06/01/2008 - "In a Flk1-TVA line that was crossed with the MMTV-PyMT transgenic mammary tumor model, tumor endothelial cells also expressed the TVA protein. "
09/20/1999 - "To develop models of human cancer we have expressed the avian retroviral receptor, TVA, under a variety of mammalian promoters in transgenic mice, thus rendering mice susceptible to infection with avian leukosis virus-derived gene vectors. "
10/01/2000 - "TVA-MR1 is comprised of the extracellular domain of the TVA receptor for subgroup A avian leukosis viruses (ALV-A), fused to the MR1 single-chain antibody that binds specifically to EGFRvIII, a tumor-specific form of the epidermal growth factor receptor. "
|4.||Sarcoma (Soft Tissue Sarcoma)
|2.||Complementary DNA (cDNA)
|4.||Messenger RNA (mRNA)
|5.||Epidermal Growth Factor Receptor (EGF Receptor)
|9.||epidermal growth factor receptor VIII